Loading chat...
OK HB2716
Bill
Status
2/1/2016
Primary Sponsor
Mike Brown
Click for details
AI Summary
-
Utilization review agents must provide notice of adverse determinations for prescription drugs or intravenous infusions at least 30 days before discontinuing the medication for patients currently receiving benefits under their health plan
-
Health carriers must establish expedited external review procedures for denials of prescription drugs or intravenous infusions, with review conducted by a health care provider who has not previously reviewed the case and is of the same or similar specialty
-
Patients denied prescription drugs or intravenous infusions they are currently receiving are entitled to expedited external review by an independent review organization and are exempt from completing internal review procedures
-
Independent review organizations must issue decisions within 72 hours for expedited external reviews, and health carriers must immediately approve coverage if the adverse determination is reversed
-
Effective date: November 1, 2016
Legislative Description
Insurance; requiring notification of a certain adverse determination within certain time period before certain medications are discontinued; effective date.
Last Action
Authored by Senator Brown (principal Senate author)
2/25/2016